Viewing StudyNCT06276868



Ignite Creation Date: 2024-05-06 @ 8:09 PM
Last Modification Date: 2024-10-26 @ 3:21 PM
Study NCT ID: NCT06276868
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-26
First Post: 2023-11-14

Brief Title: Darsilide Combined With AI Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HRHER2 Breast Cancer
Sponsor: Henan Cancer Hospital
Organization: Henan Cancer Hospital

Conditions & Keywords Data

Conditions:
Name
HER2-positive Breast Cancer
Breast Cancer
Keywords:
Name View
HER2-positive Breast Cancer View
pathologic complete response View
Dalcelli View
objective response rate View
Disease-free survival View